Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sabin-strain inactivated polio vaccine (CKD BiO)
- Development stage
- Preclinical
- Lead developer
- Sinovac Biotech
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01
Overview
PV-CKD Bio (PV) refers to a Sabin-strain inactivated polio vaccine (sIPV) currently under process development by CKD Bio. This trivalent vaccine targets poliovirus types 1, 2, and 3. Unlike traditional inactivated polio vaccines (IPV) that utilize wild-type poliovirus strains, sIPV is produced using attenuated Sabin strains. This approach significantly enhances manufacturing safety by allowing production in Biosafety Level 2 (BSL-2) facilities rather than the high-containment BSL-3 facilities required for wild-type strains. The project is notably supported by the Bill & Melinda Gates Foundation as part of the Global Polio Eradication Initiative (GPEI), aiming to provide a stable and cost-effective supply of polio vaccines to address global shortages. CKD Bio is leveraging its expertise in large-scale microbial fermentation and purification to optimize the production process for global distribution.
- Other names
- PV-CKD BioPolio vaccine
Beyond the preview
Go deeper on Sabin-strain inactivated polio vaccine (CKD BiO).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sabin-strain inactivated polio vaccine (CKD BiO).